Ibogaine Solution News
Recent news items from third-party sources, with links. Headlines are summarized; we do not endorse the content of external sources. Mention of organisations does not imply affiliation or endorsement.
Eli Lilly’s neuroscience president says the company is interested in R&D to “improve the profile of ibogaine”
FDA requests information on the design and safety of clinical trials involving ibogaine drug products
Docket FDA-2026-N-10429; public comments open through 20 November 2026.
Gabon, home to the medicinal plant behind ibogaine, wants a fairer share of its global boom
Gabon's Council of Ministers adopts a draft decree banning the export of iboga and its derivatives